195 related articles for article (PubMed ID: 20120032)
1. Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy.
Auer RC; White RR; Kemeny NE; Schwartz LH; Shia J; Blumgart LH; Dematteo RP; Fong Y; Jarnagin WR; D'Angelica MI
Cancer; 2010 Mar; 116(6):1502-9. PubMed ID: 20120032
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy.
Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Saiura A
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S390-7. PubMed ID: 24570378
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease.
Ferrero A; Langella S; Russolillo N; Vigano' L; Lo Tesoriere R; Capussotti L
J Gastrointest Surg; 2012 Apr; 16(4):806-14. PubMed ID: 22258869
[TBL] [Abstract][Full Text] [Related]
4. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?
Benoist S; Brouquet A; Penna C; Julié C; El Hajjam M; Chagnon S; Mitry E; Rougier P; Nordlinger B
J Clin Oncol; 2006 Aug; 24(24):3939-45. PubMed ID: 16921046
[TBL] [Abstract][Full Text] [Related]
5. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
7. Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect?
Gaujoux S; Goéré D; Dumont F; Souadka A; Dromain C; Ducreux M; Elias D
Dig Surg; 2011; 28(2):114-20. PubMed ID: 21540596
[TBL] [Abstract][Full Text] [Related]
8. Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases.
Pak LM; Gagnière J; Allen PJ; Balachandran VP; D'Angelica MI; DeMatteo RP; Jarnagin WR; Miga MI; Simpson AL; Kingham TP
J Gastrointest Surg; 2019 Apr; 23(4):760-767. PubMed ID: 30680630
[TBL] [Abstract][Full Text] [Related]
9. Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.
House MG; Kemeny NE; Gönen M; Fong Y; Allen PJ; Paty PB; DeMatteo RP; Blumgart LH; Jarnagin WR; D'Angelica MI
Ann Surg; 2011 Dec; 254(6):851-6. PubMed ID: 21975318
[TBL] [Abstract][Full Text] [Related]
10. [Recurrance of disappearing colorectal liver metastases after mFOLFOX6 regimen].
Ono T; Okada N; Kumamoto K; Ishibashi K; Haga N; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2214-5. PubMed ID: 22202334
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen).
Lorenz M; Müller HH; Schramm H; Gassel HJ; Rau HG; Ridwelski K; Hauss J; Stieger R; Jauch KW; Bechstein WO; Encke A
Ann Surg; 1998 Dec; 228(6):756-62. PubMed ID: 9860474
[TBL] [Abstract][Full Text] [Related]
12. Disappearing colorectal liver metastases after chemotherapy: should we be concerned?
van Vledder MG; de Jong MC; Pawlik TM; Schulick RD; Diaz LA; Choti MA
J Gastrointest Surg; 2010 Nov; 14(11):1691-700. PubMed ID: 20839072
[TBL] [Abstract][Full Text] [Related]
13. Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
Kim SS; Song KD; Kim YK; Kim HC; Huh JW; Park YS; Park JO; Kim ST
Eur Radiol; 2017 Jul; 27(7):3088-3096. PubMed ID: 27815722
[TBL] [Abstract][Full Text] [Related]
14. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
15. When is a Ghost Really Gone? A Systematic Review and Meta-analysis of the Accuracy of Imaging Modalities to Predict Complete Pathological Response of Colorectal Cancer Liver Metastases After Chemotherapy.
Muaddi H; Silva S; Choi WJ; Coburn N; Hallet J; Law C; Cheung H; Karanicolas PJ
Ann Surg Oncol; 2021 Oct; 28(11):6805-6813. PubMed ID: 33772391
[TBL] [Abstract][Full Text] [Related]
16. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.
Blazer DG; Kishi Y; Maru DM; Kopetz S; Chun YS; Overman MJ; Fogelman D; Eng C; Chang DZ; Wang H; Zorzi D; Ribero D; Ellis LM; Glover KY; Wolff RA; Curley SA; Abdalla EK; Vauthey JN
J Clin Oncol; 2008 Nov; 26(33):5344-51. PubMed ID: 18936472
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocyte-specific MRI and contrast-enhanced intraoperative ultrasonography.
Oba A; Mise Y; Ito H; Hiratsuka M; Inoue Y; Ishizawa T; Arita J; Matsueda K; Takahashi Y; Saiura A
HPB (Oxford); 2018 Aug; 20(8):708-714. PubMed ID: 29534862
[TBL] [Abstract][Full Text] [Related]
18. Disappearing liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Paredes AZ; Moris D; Gavriatopoulou M; Cloyd JM; Pawlik TM
Surg Oncol; 2019 Jun; 29():7-13. PubMed ID: 31196496
[TBL] [Abstract][Full Text] [Related]
19. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
[TBL] [Abstract][Full Text] [Related]
20. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
